Irreversible pulpitis (dental). Other diseases of pulp and periapical tissues
Conditions
Interventions
Intervention 1: First Intervention group: Name of the drug: Ketoprofen, How to use: Skin patch (patches with the trademark Ketoclin from Sinsin pharm company), Patch concentration: 60 mg, Frequency: E
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients whom their physical status is classified as ASA I Mandibular first/second molar diagnosed as irreversible pulpitis with moderate to severe pain Positive response to electric pulp test, lingering pain to cold test which validate the diagnosis of irreversible pulpitis for each tooth
Exclusion criteria
Exclusion criteria: Having any systemic disorders, gastrointestinal disease or allergy which interfere with NSAIDS Allergy to local anesthesia drugs or sulfite Teeth that are not appropriate to be restorated or teeth with severe periodontal disease which are not suitable for endodontic treatment Patients with swelling or fistula Using any analgesic drug in the past 12 hours Spontaneous pain which requires emergency treatment Not being able to give informed consent or not being able to read and write Pregnant or breastfeeding women Exit criteria include disability (for any reason) in patient's fallow-up, inappropriate endodontic treatment or a two visit treatment and using other analgesics along with the study drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity after root canal treatment. Timepoint: Pain measurement immediately after root canal treatment and 2, 4, 8,12, 24 and 48 hours after treatment. Method of measurement: Numerical rating scale (NRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeede Zadsirjan
Shahid Beheshti University of Medical Sciences
Outcome results
None listed